MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
Antibody-drug conjugates that bind to human oncology targets are disclosed. The antibody-drug conjugates comprise an Mcl-1 inhibitor drug moiety. The disclosure further relates to methods and compositions for use in the treatment of cancers by administering the antibody-drug conjugates provided here...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
23.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Antibody-drug conjugates that bind to human oncology targets are disclosed. The antibody-drug conjugates comprise an Mcl-1 inhibitor drug moiety. The disclosure further relates to methods and compositions for use in the treatment of cancers by administering the antibody-drug conjugates provided herein. Linker-drug conjugates comprising an Mcl-1 inhibitor drug moiety and methods of making same are also disclosed. |
---|---|
Bibliography: | Application Number: US202017613006 |